Abstract
In recent years, the use of the drug-coated balloon (DCB) has become possible for in-stent restenosis (ISR), but comparisons with the drug-eluting stent (DES) show that its outcomes are no different from that of DES. In this study we examined the outcomes of implanting a different type of DES for
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
